231 related articles for article (PubMed ID: 17348874)
21. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
22. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury.
Nishimura M; Hashimoto S; Takanashi M; Okazaki H; Satake M; Nakajima K
Transfus Med; 2007 Apr; 17(2):129-34. PubMed ID: 17430469
[TBL] [Abstract][Full Text] [Related]
23. Transfusion-related acute lung injury (TRALI): presentation, epidemiology and treatment.
Wallis JP
Intensive Care Med; 2007 Jun; 33 Suppl 1():S12-6. PubMed ID: 17676434
[No Abstract] [Full Text] [Related]
24. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
Danielson C; Benjamin RJ; Mangano MM; Mills CJ; Waxman DA
Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
[TBL] [Abstract][Full Text] [Related]
25. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
26. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
Askari S; Nollet K; Debol SM; Brunstein CG; Eastlund T
J Clin Apher; 2002; 17(2):93-6. PubMed ID: 12210713
[TBL] [Abstract][Full Text] [Related]
28. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
29. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
[TBL] [Abstract][Full Text] [Related]
30. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
31. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
[TBL] [Abstract][Full Text] [Related]
32. Animal models of transfusion-related acute lung injury.
Looney MR; Matthay MA
Crit Care Med; 2006 May; 34(5 Suppl):S132-6. PubMed ID: 16617257
[TBL] [Abstract][Full Text] [Related]
33. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
34. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
35. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.
Lopes LB; Fabron A; Chiba AK; Ruiz MO; Bordin JO
Transfusion; 2010 Apr; 50(4):902-8. PubMed ID: 20003053
[TBL] [Abstract][Full Text] [Related]
36. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
[TBL] [Abstract][Full Text] [Related]
37. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
[TBL] [Abstract][Full Text] [Related]
38. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
39. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
